Filter posts

BIO CEO: Five Prime Therapeutics Company Snapshot

Five Prime Therapeutics is another company that will be presenting at next week’s BIO CEO …

BIO CEO Company Snapshot: Tetraphase Pharmaceuticals

The BIO CEO & Investor Conference is now just a week away, and buzz for …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …

BIO CEO Company Snapshot: Conatus Pharmaceuticals

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & …

The Hill's Congress Blog: Innovation in medicine isn't optional - it's imperative

Earlier this week, The Hill’s Congress Blog posted an op-ed penned by Andrew von Eschenbach …

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Is 2014 a good time to invest in biotech? How many biotech IPOs will there …

Bioscience’s Bright Spots

According to Business Xpansion Journal, biotech is still big business and partnerships lead to profit. And BIO …

Couldn’t Make it to San Francisco This Week?

Me neither, so here is what I am reading for updates about the 32nd Annual JPMorgan Healthcare …

BIO White Paper Highlights Key Industry Legislation and its Impact on the Industry

Innovative biotech companies at all stages of the development process are working toward next generation …

What’s Behind the Biotech IPO Boom?

Everyone knows that it’s been a knock-out year for the biotech sector in the public …